Healthcare provider profile · identity verified

Lisa Elmore Curtis, MS, APRN, BC

Nurse Practitioner · WOODLAWN, VA · NPI 1649239021

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	548	74
Furosemide	Furosemide	503	82
Atorvastatin Calcium	Atorvastatin Calcium	288	67
Gabapentin	Gabapentin	245	43
Potassium Chloride	Potassium Chloride	199	47
Amlodipine Besylate	Amlodipine Besylate	162	38
Eliquis	Apixaban	130	33
Lorazepam	Lorazepam	124	41
Divalproex Sodium	Divalproex Sodium	120	17
Nystatin	Nystatin	114	37
Trazodone Hcl	Trazodone Hcl	107	27
Sertraline Hcl	Sertraline Hcl	104	27
Tamsulosin Hcl	Tamsulosin Hcl	103	33
Metformin Hcl	Metformin Hcl	102	16
Lisinopril	Lisinopril	101	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	95	24
Ondansetron Hcl	Ondansetron Hcl	95	36
Metoprolol Succinate	Metoprolol Succinate	92	28
Pantoprazole Sodium	Pantoprazole Sodium	92	26
Trulicity	Dulaglutide	92	17
Allopurinol	Allopurinol	91	14
Metoprolol Tartrate	Metoprolol Tartrate	91	22
Prednisone	Prednisone	91	35
Glipizide	Glipizide	82	14
Tramadol Hcl	Tramadol Hcl	81	24
Memantine Hcl Er	Memantine Hcl	77	13
Escitalopram Oxalate	Escitalopram Oxalate	74	16
Carvedilol	Carvedilol	73	16
Donepezil Hcl	Donepezil Hcl	71	12
Memantine Hcl	Memantine Hcl	70	12
Levetiracetam	Levetiracetam	59	13
Famotidine	Famotidine	58	13
Xarelto	Rivaroxaban	53	suppressed
Losartan Potassium	Losartan Potassium	48	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	suppressed
Ezetimibe	Ezetimibe	47	suppressed
Omeprazole	Omeprazole	47	11
Oxycodone Hcl	Oxycodone Hcl	47	14
Diclofenac Sodium	Diclofenac Sodium	45	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	suppressed
Mirtazapine	Mirtazapine	43	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	43	12
Digoxin	Digoxin	42	suppressed
Trimethoprim	Trimethoprim	42	suppressed
Finasteride	Finasteride	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Montelukast Sodium	Montelukast Sodium	40	suppressed
Alprazolam	Alprazolam	38	suppressed
Novolog Flexpen	Insulin Aspart	37	suppressed
Fluconazole	Fluconazole	36	15
Pregabalin	Pregabalin	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Buspirone Hcl	Buspirone Hcl	34	16
Metolazone	Metolazone	34	12
Enoxaparin Sodium	Enoxaparin Sodium	33	suppressed
Cephalexin	Cephalexin	32	18
Clonazepam	Clonazepam	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	12
Brimonidine Tartrate	Brimonidine Tartrate	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	17
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	30	21
Lacosamide	Lacosamide	30	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	27	suppressed
Tobramycin	Tobramycin	27	21
Ceftriaxone	Ceftriaxone Sodium	26	22
Baclofen	Baclofen	25	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	25	suppressed
Morphine Sulfate	Morphine Sulfate	25	19
Simvastatin	Simvastatin	25	suppressed
Lactulose	Lactulose	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Risperidone Er	Risperidone Microspheres	23	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	22	20
Amoxicillin	Amoxicillin	22	12
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Bumetanide	Bumetanide	20	12
Rosuvastatin Calcium	Rosuvastatin Calcium	20	suppressed
Carbamazepine	Carbamazepine	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Lidocaine Hcl	Lidocaine Hcl	19	16
Primidone	Primidone	19	suppressed
Atenolol	Atenolol	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Clozapine	Clozapine	16	suppressed
Cyclosporine	Cyclosporine	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Levofloxacin	Levofloxacin	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Phenobarbital	Phenobarbital	15	suppressed
Azithromycin	Azithromycin	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Rexulti	Brexpiprazole	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Fiasp	Insulin Aspart (Niacinamide)	13	suppressed
Insulin Aspart Flexpen	Insulin Aspart	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Valsartan	Valsartan	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Keppra	Levetiracetam	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Temazepam	Temazepam	12	suppressed
Torsemide	Torsemide	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Gvoke Pfs 1-Pack Syringe	Glucagon	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error